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Abstract
Background: This study estimated the prevalence and risk factors for decreased estimated glomerular filtration rate
(eGFR) in those without known hypertension, type 2 diabetes mellitus, or heavy proteinuria as a surrogate marker
for chronic kidney disease of unknown cause (CKDu) among adults in the North of Peru.
Methods: A cross-sectional study was conducted following the Disadvantaged Populations eGFR Epidemiology
(DEGREE) Study protocol. Low eGFR was defined based on a single eGFR ≤60 mL/min/1.7m2 estimated using the
CKD-EPI equation. Environmental conditions related to CKDu (i.e., work in agriculture or sugarcane, water source,
heat intolerance, and pesticide exposure) were evaluated, in addition to traditional risk factors for CKD (i.e., smoking,
heavy drinking, physical activity, hypertension, type 2 diabetes mellitus, urolithiasis, among others).
Results: A total of 1514 subjects were included in the study, mean age 45.1 (SD: 16.4), and 55.2% were females.
Overall, only 26 cases (1.7%; 95%CI: 1.1–2.5%) had an eGFR < 60 mL/min/1.7m2 compatible with CKD definition;
when those with hypertension and type-2 diabetes or heavy proteinuria were excluded, according to the DEGREE
protocol, the estimate fell to 0.9% (95%CI: 0.4–1.5%). Low physical activity levels (OR = 1.99; 95%CI: 1.18–3.34),
hypertension (OR = 2.07; 1.26–3.41), and urolithiasis (OR = 1.97; 95%CI: 1.18–3.27) were factors associated with low
eGFR.
Conclusions: A low population-based prevalence of low eGFR (as a surrogate for CKDu), both in rural and urban
settings areas, in the Northern Peru, was found. Low physical activity levels, hypertension and urolithiasis were
factors associated with low eGFR. Interventions to prevent CKD cases may be focused on well-known CV risk factors
and urolithiasis.
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Background
In less than a decade, chronic kidney disease (CKD) has
increased from the 18th to the 6th leading cause of
death worldwide, affecting nearly 850 million people and
causing 2.4 million deaths annually [1]. Age-related non-
communicable diseases (NCDs) and conditions such as
hypertension (HTN) and type 2 diabetes mellitus
(T2DM) are the main risk factors associated with CKD;
in addition, other causes include autoimmune disease,
congenital abnormalities of the urinary tract, and ob-
structive uropathy. Recently, cases of chronic kidney dis-
ease of unknown cause (CKDu), a condition not related
to NCDs, age, or any of the above aetiologies, have
emerged as a significant problem in South Asia and
Central America [2, 3].
CKDu is also referred to by various regional names in-
cluding Meso-American Nephropathy (Pacific Coast of
Central America) [4], Sri Lankan Nephropathy [5], and
Uddanam Nephropathy [6], affecting mostly young
farmers between 30 and 50 years old. The causes of
CKDu are unknown [7], but the hypothesized causes in-
clude pesticide exposure and heavy metal poisoning as-
sociated with agriculture work, as well as heat stress in
low-altitude areas. The latter hypothesis proposes that
environmental heat, in combination with recurrent de-
hydration and high-levels of physical exertion, lead to re-
current acute kidney injury episodes and eventually
CKD [8]. However, CKDu has not been reported in
other countries where this combination of risk factors
could be found [9, 10].
Latin America, mainly Mexico, has amongst the highest
rates globally of renal replacement therapy (RRT), includ-
ing haemodialysis, peritoneal dialysis, and kidney trans-
plant [11]. However, epidemiologic data on CKD are
mostly from Brazil, and a few other countries in South
America. Although, in the Brazilian northeast region the
temperature could regularly rise over 38 °C (100 °F), nei-
ther a higher prevalence of CKD, nor CKDu cases, have
been reported among Brazilian agricultural workers [12].
Peru, a country closer to the Equator, has reported a CKD
prevalence of 13 to 21% [13, 14], which is comparable to
that in El Salvador and Nicaragua [15, 16]. Approximately
50% of the end stage population of CKD in Peru does not
receive dialysis or renal replacement therapy (RRT), since
the health system does not have the necessary resources
(technological and human) [17, 18]. Moreover, in Peru,
2.0% of the deaths at the national level were attributable
to CKD, being in the top ten causes of death [19].
Therefore, the purpose of this study was to estimate
the prevalence of low eGFR (< 60 ml/min /1.7 m2) in
those without known HTN, T2DM or heavy proteinuria
as a surrogate marker for CKDu among participants
from the Tumbes region, in the North of Peru. In
addition, we assessed the factors associated with the
prevalence of impaired kidney function (i.e., low eGFR)
in general and surrogate CKDu in particular.
Methods
Study design and setting
A cross-sectional study was conducted following the
protocol of the Disadvantaged Populations eGFR Epi-
demiology Study (DEGREE) [20]. This study was con-
ducted in Tumbes, a region located in the North of
Peru, on the border with Ecuador, and where approxi-
mately 90% of the population is urban. In addition,
nearly 20 and 1% of the population respectively are con-
sidered poor and extremely poor, and 15% do not have
basic sanitation services [21].
Tumbes was chosen for the following reasons (see
Table 1 for comparison with other regions where CKDu
has been documented): agriculture workers (up to 10%
of the active economic population), contamination of
the Rio Puyango, the main source of water (i.e., cad-
mium and arsenic), and warm climate with low precipi-
tation rates. The temperature of the city has an annual
average temperature of 27 °C, reaching almost 35 °C dur-
ing the summer [22].
Study participants
Adults aged ≥18 years, resident in Tumbes, were invited
to participate using the most updated census in the area
(2014). Pregnant women, those who declined to give
blood and urine samples, and those with mobility dis-
abilities preventing bioimpedance assessment, were ex-
cluded from the study. The sample was stratified by
population group, so that, participants were from urban
and rural areas in similar proportions (50%). In addition,
we decided not to recruit more women after their num-
ber reached 60% for each of these two subgroups.
Outcome
We calculated the estimated Glomerular Filtration Rate
(eGFR) using the Chronic Kidney Disease – Epidemi-
ology Collaboration (CKD-EPI) equation. We defined
three categories of kidney function based on eGFR re-
sults: moderate or established kidney dysfunction (< 60
mL/min/1.7m2), mild kidney dysfunction (60–90mL/
min/1.7m2), and normal (≥90 mL/min/1.7m2). CKD was
defined as the proportion of individuals with moderate
or established kidney function (eGFR < 60 mL/min/
1.7m2) in the overall sample; whereas the prevalence of
CKDu was estimated using the same indicator but ex-
cluding individuals with previous diagnosis of HT and/
or T2DM, and those having a heavy proteinuria, defined
as 3+ in urine dipstick (equivalent to ≥ 300 mg/dl of pro-
tein) according to the DEGREE protocol [20].
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Questionnaires
During the first visit, questionnaires were used to gather
information on socio-demographic factors (age, sex) and
socioeconomic status (education, employment status,
house-hold income and health insurance). Environmen-
tal conditions associated with CKDu (previous or
current work in agriculture or sugarcane, water source,
heat, and pesticide exposure) were addressed. Informa-
tion on past medical history was focused on cardiovascu-
lar diseases (HT, T2DM, myocardial infarction, stroke,
and hypercholesterolemia), and behavioural risk factors
(alcohol, smoking, and physical activity). We also in-
cluded questions on CKD and its associated causes, in-
cluding congenital kidney malformation, diabetic
nephropathy, polycystic kidney disease, urolithiasis, use
of nephrotoxic medications (non-steroidal anti-
inflammatory, parenteral use of antibiotics, and herbal
medicine), tuberculosis, hepatitis B, and leptospirosis.
Clinical assessment
Participants were invited for another visit to obtain
blood samples for fasting glucose and creatinine, urine
samples (dipstick urinalysis) and clinical examination.
We asked the participants to refrain from eating meat,
caffeine, tobacco and paracetamol 8 h prior to taking the
sample. The clinical evaluation included three blood
pressure measurements taken after 5 min of resting
(seated) position and 5min apart from each other (eval-
uated with an automatic digital calibrated sphygmoman-
ometer OMRON HEM-780, Tokyo, Japan), stand height
(cm), weight (kg) by standardized procedures, and body
composition (i.e. body fat percentage), for which we used
a supine bioimpedance analyzer balance (BodyStat 1500,
BodyStat Limited, British Islands) calibrated at a single
frequency (50 Hz).
Analysis of biological samples
Urine dipstick analyses yielded semi-quantitative values
of blood, proteins, leukocytes, glucose, pH and urine
density. We measured serum creatinine in 5 ml of blood
sample using a mass spectrometry method calibrated ac-
cording to isotope dilution (IDMS, English acronym). As
in the DEGREE Study protocol, serum samples were
stored at − 20 °C for future Cystatin C determination.
Other variables of interest
We also gathered information on key reported risk fac-
tors for CKD and CKDu. Age was considered as both a
continuous and categorical variable. Level of education
was classified in three categories (< 7, 7–11, ≥12 years of
education). We also considered socioeconomic status as
monthly household income dichotomised with a cut-off
point of 850 PEN (250 USD, minimum salary wage at
the moment of the study).








Population 240,590 14,807 238,244 8,017,894 21,358,975 206,264
Urbanicity 94.1% (urban) 24% (urban) 67% (urban) 77% (urban) 77% (urban) 81.6% (urban)
Climate Arid and
subtropical
Hot tropical Tropical Arid Tropical Tropical
Humidity 76% 70–90% 62–100% Over 90% 70–95% 65–80%
Precipitation 131.4 mm 1067mm 13 to 155mm 4mm (no rain
season)
200 mm 181mm
Temperature 21–40 °C 34.3 °C 23–35 °C 32.6 °C 36 °C 35 °C
Average annual
temperature
25.3 °C 31.5 °C 26 °C 26.2 °C 27 °C 32.5 °C
Altitude Sea level 60–70 m 90m 4–8 m 81m 109m
Agriculture Rice, lime, banana Rice coconuts and
cashew











Arsenic Silica Arsenic, cadmium Cadmium Cadmium Aluminum, arsenic,
lead
Leptospira 0.02–5% 61.8% – 49.7% 53% 36%
Hypertension rates 26.9% 38.5–615% 30% – 26% 22%
Type 2 diabetes
mellitus
10.3% 7.2–30% 8.8% – 8.6% 10%
CKDu < 1% 1.6–4.8%, up to 60% 25% 17.7% 15–21% 19%
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We also collected information on ever working in agri-
culture, sugarcane, and pesticide use; these variables
were built as categorical (yes/no). Due to potential
sources of contamination of water, we chose access to
piped water (yes/no) as the variable to be assessed. Heat
intolerance, a proxy of heat exposure, was considered to
have occurred if the participant reported to have fainted
when exposed to hot weather. We built a variable anal-
gesic/antibiotic use due to the variety of potential
nephrotoxic medications (including herbal medicine use)
usually sold without prescriptions. For this, we focused
on the ever use of analgesics and intramuscular antibi-
otics. In addition, history of some diseases because their
impact on CKD was also included: tuberculosis, hepatitis
B, and leptospirosis.
Heavy drinking (consuming at least 6 alcoholic stand-
ard beverages, monthly), and current smoking within the
last 12 months were also included. Physical activity was
dichotomised in low vs. moderate/high according to the
International Physical Activity Questionnaire (IPAQ).
Body mass index (BMI) was calculated according to the
WHO recommendations, and then split into three cat-
egories (< 25 kg/m2, between 25 and < 30 kg/m2, and
≥30 kg/m2). HT was defined as a systolic blood pressure
≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg
and/or previous diagnosis by a physician and current
medication. To estimate the values for systolic and dia-
stolic blood pressure, we used the mean of the last two
(out of three) measurements conducted. T2DM was de-
fined as a fasting (8–12 h) glucose ≥126 mg/dl or self-
report of previous diagnosis and treatment. The cut-off
point for glycosuria was ≥250 mg/dl, urinary density
≥1020 (as a proxy for dehydration) and proteinuria if the
urine level marker of protein was ≥30mg/dl (equivalent
to 1+ in urine dipstick).
Sample size
We planned a sample size of 750 participants in each
population group (rural and urban). Assuming an ex-
pected CKDu prevalence of 5%, with 1500 individuals in
total, we will have a precision of 1%. In addition, this
precision would be of 1.6% if only 750 subjects are eval-
uated as in each study group.
Data analysis
We conducted descriptive analyses of socio-
demographic, socioeconomic, cardiovascular risk profile
and CKD risk profiles according to the study population
group (rural and urban) and kidney function. These
comparisons were conducted for the overall sample
(compatible with CKD) and among those without known
HT, T2DM or heavy proteinuria (as a proxy of CKDu).
Chi-square tests for comparison of categorical variables,
and Student’s t test or Mann-Whitney U was used for
comparison of numerical variables. In addition, the
prevalence of CKD and CKDu were also estimated with
their respective 95% confidence intervals (95%CI).
As very few cases with eGFR levels compatible with
CKD and CKDu (i.e., eGFR < 60mL/min/1.7m2) were
found, we analysed factors associated with impaired kid-
ney function (eGFR < 90mL/min/1.7m2) rather than fac-
tors associated with eGFR< 60. We used logistic
regression models to determine associated factors for
impaired kidney function. As a result, crude model and
adjusted models are shown. The first adjusted regression
model was controlled by age (as continuous variable)
and sex; whereas the second regression model included
also population group and education level as potential
confounders.
Results
Characteristics of the study participants
A total of 1514 of 1818 (83.3%) contacted subjects con-
sented to be included in the study. Socio-demographic,
occupational and lifestyle characteristics of the overall
sample are summarized in Supplementary Table 1. More
than half of participants were < 50 years old (overall
mean age 45.1 [SD: 16.4] years) and 55.2% were females.
The employment rate was 55.9% and higher in men
(89.4%) than women (28.6%). Only 33.9% of the study
population reported to have worked in agriculture and
were mostly male rural dwellers (56.2%). The prevalence
of measured HT was 15.6% (mean SBP: 115.7 [SD: 18.9])
and increased to 20.8% when self-reported HT diagnosis
was added (Supplementary Table 2). The mean fasting
glucose was 95.9 (SD: 39.5) mg/dl, with a prevalence of
8.3% for T2DM. The mean BMI was 27.5 (SD: 4.5) kg/
m2 with a prevalence of 43.5% for overweight and 26.8%
for obesity. A total of 274 (18.1%) participants self-reported
a previous diagnosis of CKD, although mean creatinine was
0.7 (SD: 0.2) mg/dl, and urolithiasis was reported in 15.7% of
the total sample (Supplementary Table 3).
After excluding those with known HT, T2DM or
heavy proteinuria, a total of 1272 subjects were analysed.
Socio-demographic and lifestyle characteristics of this
population are summarized in Table 2. Over 70% of the
subjects were younger than 50 years and over half of
them were employed, 20.8% reported having worked
with pesticides, and 33.7% had worked in agriculture. Al-
most all the urban dwellers had access to piped water.
Undiagnosed HT and T2DM were found in 11.2 and
2.1% of the population (Table 3). Of note, only 2 (0.2%)
had proteinuria (1+ in urine dipstick).
Prevalence of low eGFR and proxy CKDu
In the overall sample, and according to the CKD-EPI
formula, only 26 cases (1.7%; 95%CI: 1.1–2.5%) had an
eGFR < 60mL/min/1.7m2 compatible with the definition
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Table 2 Sociodemographic, occupational and lifestyle characteristics by study group and sex (n = 1272)
Urban Rural
Male Female Male Female
(n = 261) (n = 364) (n = 298) (n = 349)
Age, mean (SD) 45.2 (16.6) 41.9 (14.4) 45.0 (15.9) 39.3 (14.4)
Age (categorized)
< 50 years 165 (63.2) 266 (73.1) 191 (64.1) 274 (78.5)
50+ years 96 (36.8) 98 (26.9) 107 (35.9) 75 (21.5)
Education (in years)
0–7 years 69 (26.4) 96 (26.4) 115 (38.6) 129 (36.9)
7–11 years 128 (49.1) 161 (44.2) 125 (42.0) 136 (39.0)
> 12 years 64 (24.5) 107 (29.4) 58 (19.5) 84 (24.1)
Work
Employed 229 (87.8) 112 (30.7) 286 (96.0) 99 (28.4)
Student 10 (3.8) 18 (5.0) 6 (2.0) 15 (4.3)
Homemaker & unpaid 0 (0.0) 223 (61.3) 1 (0.3) 223 (63.8)
retired 10 (3.8) 0 (0.0) 0 (0.0) 2 (0.6)
Unemployed 11 (4.6) 11 (3.0) 5 (1.7) 10 (2.9)
Pesticide exposure (ever)
Yes 28 (10.7) 5 (1.4) 199 (66.8) 32 (9.2)
Sugarcane work
Yes 3 (1.2) 1 (0.3) 18 (6.0) 6 (1.7)
Agriculture work
Yes 53 (20.3) 9 (2.5) 259 (86.9) 107 (30.7)
Heat exposure at work
Yes 97 (37.2) 16 (4.4) 187 (62.8) 71 (20.3)
Monthly household income
< 850 PEN (≈258 USD) 110 (48.9) 194 (64.9) 159 (61.2) 231 (78.6)
Water source
Piped water 232 (99.1) 305 (100.0) 10 (3.4) 15 (4.4)
Well 2 (0.9) 0 (0.0) 193 (66.4) 229 (67.2)
River 0 (0.0) 0 (0.0) 62 (21.3) 54 (15.8)
Trunk 0 (0.0) 0 (0.0) 26 (8.9) 43 (12.6)
Health insurance
Yes 224 (85.8) 330 (90.7) 239 (80.6) 315 (90.3)
Current smoking
Yes 63 (24.1) 5 (1.4) 81 (27.2) 6 (1.7)
Heavy drinking
Yes 53 (20.3) 7 (1.9) 67 (22.5) 3 (0.9)
Physical activity
Low 189 (72.4) 334 (91.8) 164 (55.0) 288 (82.5)
Medicine intake risk
Yes 100 (38.3) 222 (61.0) 129 (43.3) 194 (55.6)
Herbal medicine use
Yes 108 (41.4) 154 (42.3) 158 (53.0) 181 (51.9)
Ruiz-Alejos et al. BMC Nephrology           (2021) 22:37 Page 5 of 12
of CKD, whereas 16.6% (95%CI: 14.8–18.6%) had and
eGFR ≥60 but < 90mL/min/1.7m2. When these esti-
mates were calculated in the subsample according to the
DEGREE protocol, only 11 individuals (0.9%; 95%CI:
0.4–1.5%) had an eGFR < 60mL/min/1.7m2, compatible
with CKDu.
In bivariate analysis, those with impaired kidney func-
tion (eGFR < 60 mL/min/1.7m2) were older, male, with
Table 3 Clinical characteristics by study group and sex (n = 1272)
Urban Rural
Male Female Male Female
(n = 261) (n = 364) (n = 298) (n = 349)
SBP, mean (SD) 118.3 (13.8) 107.7 (13.5) 120.0 (16.6) 106.9 (14.9)
DBP, mean (SD) 79.5 (9.9) 75.4 (9.4) 78.8 (10.6) 73.8 (9.9)
Hypertension
Yes 37 (14.2) 23 (6.3) 54 (18.1) 29 (8.3)
Previous stroke
Yes 0 (0.0) 1 (0.3) 0 (0.0) 2 (0.6)
High cholesterol
Yes 29 (11.1) 59 (16.3) 31 (10.7) 89 (26.3)
Tuberculosis
Yes 5 (1.9) 2 (0.6) 9 (3.0) 5 (1.4)
Hepatitis B
Yes 0 (0.0) 3 (0.8) 6 (1.4) 1 (0.3)
Leptospirosis
Yes 0 (0.0) 2 (0.6) 2 (0.7) 1 (0.3)
CKD (self-report)
Yes 50 (19.2) 67 (18.4) 42 (14.1) 55 (16.1)
Urolithiasis
Yes 46 (17.6) 58 (15.9) 38 (12.8) 50 (14.3)
Glucose, mean (SD) 88.6 (16.9) 90.3 (20.2) 88.7 (16.0) 88.8 (21.7)
Type 2 diabetes
Yes 4 (1.5) 9 (2.5) 5 (1.7) 9 (2.6)
Body fat %, mean (SD) 23.6 (6.0) 38.4 (6.3) 23.5 (5.7) 38.3 (6.3)
Body mass index, mean (SD) 27.3 (4.4) 28.5 (4.6) 25.7 (3.8) 27.5 (4.5)
BMI categorized
Normal 77 (29.5) 83 (22.8) 129 (43.3) 102 (29.2)
Overweight 122 (46.7) 152 (41.8) 128 (43.0) 151 (43.3)
Obese 62 (23.8) 129 (35.4) 41 (13.7) 96 (27.5)
Creatinine, mean (SD) 0.9 (0.2) 0.6 (0.1) 0.9 (0.1) 0.6 (0.1)
eGFR, mean (SD) 100.6 (17.4) 111.5 (16.0) 104.1 (16.0) 114.0 (17.3)
Urine density
≥1020 166 (63.6) 203 (55.8) 216 (72.5) 230 (65.9)
Urine protein
Negative 260 (99.6) 363 (99.7) 297 (99.7) 348 (99.7)
Trace 0 (0.0) 1 (0.3) 1 (0.3) 0 (0.0)
Positive 1 (0.4) 0 (0.0) 0 (0.0) 1 (0.3)
Glucosuria
≥ 250mg/dl 6 (2.3) 7 (1.9) 1 (0.3) 5 (1.4)
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low education level, reported having worked in agricul-
ture, had more access to piped water, reported using
herbal medicine, had higher systolic and diastolic blood
pressure, and consequently higher HTN prevalence, and
low urine density (Table 4).
Factors associated with impaired kidney function (eGFR <
90mL/min/1.7m2)
Table 5 shows the findings adjusted for age and sex
(model 1) and further adjusted for population group and
education. In the fully adjusted model, low physical ac-
tivity levels (OR = 1.99; 95% CI: 1.18–3.34), HTN (OR =
2.07; 95% CI: 1.26–3.41), and urolithiasis (OR = 1.97;
95% CI: 1.18–3.27) were factors associated with impaired
kidney function. On the other hand, sugarcane work was
associated with lower odds of impaired kidney function
(OR = 0.28; 95% CI: 0.08–0.96) in adjusted model. The
same factors, but not sugarcane work, were associated
with impaired kidney function when the analysis was




The findings of this study are interesting because this
has been conducted in a setting with high frequency of
environmental exposures that have been hypothesized to
be associated with CKDu in other populations. Thus,
one might have expected to find a substantial prevalence
of low eGFR (surrogate of CKDu), but in fact we found
a prevalence of less than 1%, consistent with what has
been observed in other ‘non-epidemic’ settings. Factors
associated with increased probability of impaired kidney
function were HTN, urolithiasis, and low physical activ-
ity levels; nevertheless, sugarcane work was associated
with low probability of impaired kidney function but
only in the DEGREE protocol subsample and not in the
entire sample.
Comparison with previous studies
There is strong evidence that CKDu exists in Central
America [23] and Sri Lanka [24]. There have been un-
confirmed case reports in other locations such as India
[25], Saudi Arabia [26], and Egypt and Senegal [27]. A
cross-sectional study found CKDu prevalence in most
affected areas of Sri Lanka was as high as 22.9% [24].
Globally, the increasing prevalence of end-stage CKD in
African American, Hispanic and Native American popu-
lations is at least 50% attributable to T2DM [20]. In con-
trast, the contribution of CKDu to overall CKD burden
in Peru seems to be negligible.
Tumbes is a region located on the border with
Ecuador, and the inhabitants have a constant exposure
to a hot and sub-tropical weather. Most of the regions
where CKDu has been reported have a tropical environ-
ment, with humidity levels above 85%; however, Tumbes
climate is arid, and thus, subtropical, and humidity tends
to be lower, compared to Uddanam, El Salvador and
Nicaragua. Nevertheless, considering the variability of
tropical climate, the annual average ranges of humidity,
precipitation, and annual temperature in the hotspots
for CKDu are not considerably different (Table 1).
Despite the fact that exposures to agrochemicals and
heavy metal are frequent in Tumbes region [28], we
could not find a high number of cases of CKDu. Mining
activities in Ecuador led to heavy metal contamination
of Rio Puyango [29], the main source of water for
dwellers in Tumbes; and nearly 60 and 90% of the rural
male dwellers from our study reported previous pesticide
exposure and having worked in agriculture, respectively.
The evidence supporting pesticide use and its relation-
ship with CKDu relies on chronic exposure more than
acute major nephrotoxic damage [30]. Thus, male
farmers from Chichigalpa (Nicaragua) had one of the
highest prevalence of impaired kidney function in the re-
gion (41.9%) and this was reported to be associated with
sugarcane cutting and pesticide inhalation [31]. A rela-
tively recent systematic review found no association be-
tween CKDu and pesticide exposure [32], which was the
case in our study. Surprisingly, sugarcane work was asso-
ciated with lower odds of impaired kidney function, per-
haps due to residual confounding or over-adjustment as
few individuals reported work in sugarcane.
The factors that we found to be associated with im-
paired kidney function in our study are consistent with
those widely reported in literature, and are not related to
CKDu. For example, a recent systematic review has re-
ported that combined aerobic and resistance exercise
improves renal function, especially among patients with
CKD [33]. HTN and obstructive nephropathy have been
described as main causes of impaired kidney function.
Public health relevance
CKD has emerged as a public health concern in Peru
due to its increasing mortality and lack of early detec-
tion. A study using healthcare and death records from
the Peruvian Ministry of Health evidenced an increase of
300% of CKD prevalence between 2010 and 2016, espe-
cially in the Tumbes region [34]. In addition, another
study reported that the proportionate mortality due to
CKD has also increased in this region during the last 15
years [19].
Despite of this, cases of CKD are mainly attributed to
HTN and T2DM, but also obstructive nephropathy and
low physical activity levels have been described. This
study shows that very few cases are probably due to
CKDu, even though the region selected for this study
may have several environmental and weather conditions
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Table 4 Baseline characteristics of study population by eGFR results (n = 1272)
eGFR categories p-
value< 60 60–90 ≥90
(n = 11) (n = 165) (n = 1096)
Age, mean (SD) 66.5 (13.8) 62.4 (14.4) 39.3 (12.9) < 0.001
Age categorized
< 50 years 1 (9.1) 34 (20.6) 861 (78.6) < 0.001
50+ years 10 (90.9) 129 (79.4) 235 (21.4)
Sex
Male 8 (72.7) 107 (64.9) 444 (40.5) < 0.001
Female 3 (27.3) 58 (35.1) 652 (59.5)
Site
Urban 7 (63.6) 95 (57.6) 523 (47.7) 0.04
Rural 4 (36.7) 70 (42.4) 573 (52.3)
Education (in years)
0–7 years 8 (72.7) 110 (66.7) 291 (26.6) < 0.001
7–11 years 3 (27.3) 38 (23.0) 509 (46.4)
> 12 years 0 (0.0) 17 (10.3) 296 (27.0)
Pesticide exposure (ever)
Yes 2 (18.1) 35 (21.2) 227 (20.7) 0.97
Sugarcane work
Yes 1 (9.1) 3 (1.8) 24 (2.2) 0.28
Agriculture work
Yes 4 (36.4) 69 (41.8) 355 (32.4) 0.06
Heat exposure at work
Yes 3 (27.3) 52 (31.5) 316 (28.8) 0.77
Monthly household income
< 850 PEN (≈258 USD) 3 (50.0) 97 (69.3) 594 (63.7) 0.34
Water source
Piped water 6 (60.0) 90 (58.4) 465 (46.2) 0.007
Well 2 (20.0) 39 (25.3) 383 (38.1)
River 0 (0.0) 19 (12.4) 97 (9.6)
Trunk 2 (20.0) 6 (3.9) 61 (6.1)
Health insurance
Yes 11 (100.0) 150 (90.9) 947 (86.4) 0.12
Current smoking
Yes 1 (9.1) 20 (12.1) 134 (12.2) 0.95
Heavy drinking
Yes 0 (0.0) 12 (7.3) 118 (10.8) 0.21
Physical activity
Low 8 (72.7) 137 (83.0) 830 (75.7) 0.11
Medicine intake risk
Yes 4 (36.4) 82 (49.7) 559 (51.0) 0.60
Herbal medicine use
Yes 7 (63.6) 98 (59.4) 496 (45.3) 0.002
SBP, mean (SD) 130.8 (26.1) 125.4 (19.7) 110.4 (14.0) < 0.001
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that have been hypothesized to cause CKDu; these in-
clude humidity, temperature, pesticide use, and metal
contamination (Table 1). From the public health per-
spective, interventions to prevent CKD cases may be fo-
cused on well-known CV risk factors (i.e. HTN and
T2DM) as well as promoting physical activity and pre-
vent or appropriately treat urolithiasis. According to our
results, it does not appear that CKDu is a major prob-
lem, at least in the Tumbes region. This finding is po-
tentially important internationally, since the cause(s) of
CKDu are still unknown, but the main hypotheses in-
volve heat and pesticide exposure – we have found
CKDu to not be present in a region which has these hy-
pothesized causal exposures.
Strengths and limitations
This exploratory study has several strengths including
appropriate sample size, high response rates, representa-
tiveness, and internationally referenced laboratory valid-
ation. The sample size was considered to analyse
associated factors of CKD and CKDu among rural and
urban dwellers, as performed in previous studies [35,
36]. As expected, recruited subjects showed a similar risk
profile for CKD and CKDu considering environmental
and socio-demographic factors.
Limitations, however, are also present. First, this is a
cross-sectional study, and we are not able to confirm
that the relevant exposures (e.g. pesticides) occurred be-
fore the relevant outcomes (low eGFR). Nevertheless,
Table 4 Baseline characteristics of study population by eGFR results (n = 1272) (Continued)
eGFR categories p-
value< 60 60–90 ≥90
DBP, mean (SD) 83.5 (14.8) 81.1 (11.5) 75.8 (9.8) < 0.001
Hypertension
Yes 4 (36.4) 44 (26.7) 95 (8.7) < 0.001
High cholesterol
Yes 2 (18.2) 36 (22.0) 170 (15.8) 0.14
Tuberculosis
Yes 0 (0.0) 3 (1.8) 18 (1.7) 0.90
Hepatitis B
Yes 0 (0.0) 1 (0.6) 7 (0.6) 0.97
Leptospirosis
Yes 0 (0.0) 0 (0.0) 5 (0.5) 0.67
Urolithiasis
Yes 2 (18.2) 33 (20.0) 157 (14.3) 0.16
Glucose, mean (SD) 104.4 (54.6) 91.7 (19.1) 88.7 (18.4) 0.005
Type 2 diabetes
Yes 1 (9.1) 4 (2.4) 22 (2.0) 0.26
Body fat %, mean (SD) 32.8 (10.2) 33.6 (9.5) 31.7 (9.5) 0.05
Body mass index, mean (SD) 25.9 (4.5) 27.2 (4.3) 27.4 (4.5) 0.54
BMI categorized
Normal 5 (45.5) 52 (31.5) 334 (30.5) 0.64
Overweight 5 (45.5) 74 (44.9) 474 (43.3)
Obese 1 (9.0) 39 (23.6) 288 (26.2)
Urine density
≥1020 4 (36.4) 78 (47.3) 733 (66.9) < 0.001
Urine protein
Negative 10 (90.9) 165 (100.0) 1093 (99.7) < 0.001
Trace 1 (9.1) 0 1 (0.1)
Positive 0 (0.0) 0 2 (0.2)
Urine glucose
≥ 250mg/dl 1 (9.1) 0 (0.0) 18 (1.6) 0.03
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the focus of the study was to determine the prevalence
of CKD and CKDu and factors evaluated were those
which are considered as potential causes of these condi-
tions. Second, only a single eGFR measurement was car-
ried out, so we were not able to confirm cases of CKD
as we were unable to demonstrate chronicity – how-
ever, this would not affect our main finding that
CKDu prevalence was very low. In addition, the
CKD–EPI equation has not been validated in Peru
and may potentially underestimate the number of
cases with eGFR< 60, especially among women [37].
Nonetheless, due to the low prevalence of eGFR< 60
and even < 90 in young adults, it is unlikely that this
would explain our findings. In addition to that, an
eGFR< 90 alone has not been associated with the pre-
diction of poor outcomes (e.g. cardiovascular disease,
end-stage kidney disease, etc). Third, recall bias may
be a concern as we collected information by using
self-report of current and past behaviours and other
exposures. In addition, some questions (i.e. heat in-
tolerance or analgesic/antibiotic use) used to capture
information were not previously validated. Finally, se-
lection bias may arise as only one Peruvian region
with the environmental characteristics for CKDu was
chosen for the study.
Conclusions
Despite having appropriate environmental conditions
and work-related stressors that have been hypothesized
to cause CKDu, this study found a low population-based
prevalence of CKDu, both in rural and urban settings
areas in Tumbes, a region in the Northern Peru. Low
physical activity levels, HTN and urolithiasis were the
factors associated with CKD in this sample. From the
public health perspective, interventions to prevent or
delay CKD cases may be focused on well-known CV risk
factors and urolithiasis.
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cause; CKD-EPI: Chronic Kidney Disease – Epidemiology Collaboration;
Table 5 Factors associated with impaired kidney function*: adjusted models (n = 1272)
Adjusted model 1 Adjusted model 2
OR (95%CI) OR (95%CI)
Pesticide exposure (yes) 0.55 (0.33–0.92) 0.70 (0.39–1.25)
Sugarcane work (yes) 0.25 (0.07–0.82) 0.28 (0.08–0.96)
Agriculture work (yes) 0.55 (0.35–0.86) 0.72 (0.40–1.29)
Heat exposure at work (yes) 0.72 (0.45–1.14) 0.84 (0.51–1.37)
Water source (access to piped water) 1.66 (1.11–2.49) 0.96 (0.42–2.20)
Current smoking (yes) 0.66 (0.36–1.23) 0.66 (0.36–1.23)
Heavy drinking (yes) 0.91 (0.44–1.87) 0.97 (0.47–2.01)
Physical activity (low levels) 2.23 (1.24–3.71) 1.99 (1.18–3.34)
Medicine intake risk (yes) 1.03 (0.69–1.54) 1.04 (0.69–1.56)
Herbal medicine use (yes) 0.99 (0.66–1.48) 1.05 (0.69–1.58)
Hypertension (yes) 1.94 (1.19–3.17) 2.07 (1.26–3.41)
Type 2 diabetes (yes) 0.99 (0.31–3.13) 1.11 (0.34–3.61)
Body mass index
Overweight 1.22 (0.76–1.98) 1.17 (0.72–1.91)
Obesity 1.28 (0.74–2.22) 1.11 (0.63–1.96)
Urolithiasis (yes) 2.06 (1.24–3.40) 1.97 (1.18–3.27)
Tuberculosis (yes) 1.13 (0.28–4.58) 1.20 (0.30–4.81)
Hepatitis B (yes) 1.66 (0.16–16.9) 1.74 (0.16–19.1)
Leptospirosis (yes) – –
Bold estimates are statistically significant (p<0.05). Impaired kidney function was defined as eGFR < 90mL/min/1.7m2
Adjusted model 1: controlled by age and sex
Adjusted mode 2: controlled by age, sex, population group, and education
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